ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,545Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 97

$386K Total Retail Price of All Prescriptions

Rank: 34 out of 97

586 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
17% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Dakota
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 586 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

4% of this provider’s 586 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 7,729 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Dakota
LISINOPRIL 347 320 1 4
LEVOTHYROXINE SODIUM 346 306 2 1
AMLODIPINE BESYLATE 339 339 3 6
OMEPRAZOLE 304 268 4 5
FUROSEMIDE 302 294 5 3
HYDROCHLOROTHIAZIDE 272 267 6 9
METOPROLOL TARTRATE 260 246 7 7
PRAVASTATIN SODIUM 247 215 8 28
METOPROLOL SUCCINATE 238 237 9 8
METFORMIN HCL 238 198 9 12
SIMVASTATIN 237 232 11 2
WARFARIN SODIUM 183 166 12 11
POTASSIUM CHLORIDE 166 156 13 10
ATORVASTATIN CALCIUM 128 118 14 14
DICLOFENAC POTASSIUM 117 91 15 166
ALLOPURINOL 95 95 16 22
LOSARTAN POTASSIUM 94 94 17 13
ATENOLOL 91 77 18 15
SERTRALINE HCL 89 87 19 16
ZOLPIDEM TARTRATE 88 76 20 32
CEFDINIR 87 71 21 149
CLOPIDOGREL 75 73 22 34
ISOSORBIDE MONONITRATE ER 73 73 23 27
CIPROFLOXACIN HCL 70 58 24 60
TAMSULOSIN HCL 68 68 25 31
CITALOPRAM HBR 67 61 26 20
TERAZOSIN HCL 66 63 27 106
VERAPAMIL ER 64 47 28 90
AZITHROMYCIN 63 57 29 64
PLAVIX 61 58 30 46
CARVEDILOL 61 61 30 25
PEN NEEDLE 60 40 32 57
LANTUS SOLOSTAR 59 44 33 41
DIGOXIN 57 50 34 26
LOSARTAN-HYDROCHLOROTHIAZIDE 57 55 34 49
FLUTICASONE PROPIONATE 55 50 36 52
RAMIPRIL 53 52 37 68
CLONIDINE HCL 52 52 38 72
PAROXETINE HCL 51 51 39 56
MIRTAZAPINE 51 39 39 35
GLIMEPIRIDE 50 50 41 39
BUMETANIDE 50 46 41 78
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 25, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.